(Washington, DC) The United States food and drug administration FDA has granted fast-track status for a potential stem cell treatment of amyotrophic lateral sclerosis ALS.
(Washington, DC) The United States food and drug administration FDA has granted fast-track status for a potential stem cell treatment of amyotrophic lateral sclerosis ALS.